kaposi
sarcomaassoci
herpesviru
kshv
etiolog
agent
kaposi
sarcoma
ks
common
cancer
afflict
hivinfect
ks
character
three
histolog
featur
angiogenesi
inflamm
kshv
also
associ
two
b
cell
lymphoprolif
disord
primari
effus
lymphoma
pel
multicentr
castlesman
diseas
mcd
kshv
belong
subfamili
genu
rhadinoviru
first
describ
kshv
intern
highli
orchestr
complic
event
yet
thoroughli
understood
initi
step
viru
entri
process
revers
step
bind
attach
target
step
primarili
achiev
kshv
interact
ubiquit
express
cell
surfac
receptor
heparan
sulfat
hs
attach
cell
enabl
kshv
interact
entri
promot
receptor
allow
viru
eventu
enter
recent
studi
determin
interferon
ifn
induc
express
significantli
enhanc
kshv
infect
human
b
endotheli
opposit
process
overexpress
microrna
mirna
significantli
lower
express
thu
viru
entri
conclud
play
crucial
role
promot
earli
stage
kshv
infect
cell
vitro
past
year
sever
novel
gene
downstream
type
ifn
signal
inhibit
infect
individu
multipl
famili
virus
describ
two
genet
function
distinct
famili
interferon
stimul
gene
isg
antivir
properti
ifninduc
protein
tetratricopeptid
repeat
ifit
ifitm
ifit
contribut
antivir
state
virus
bind
compon
translat
initi
complex
inhibit
protein
contrast
ifitm
block
viral
infect
entri
ifitm
doubleedg
sword
come
influenc
viral
entri
also
enhanc
viral
interestingli
express
enhanc
kshv
infect
cell
also
infect
cell
close
relat
herpesviru
belong
subfamili
epsteinbarr
viru
ebv
kshv
ebv
relev
human
therefor
conduct
studi
confirm
role
kshv
ebv
infect
vitro
vivo
vivo
studi
use
murin
serv
good
model
understand
kshv
ebv
herein
provid
pioneer
evid
demonstr
key
role
vitro
vivo
infect
recent
conclud
studi
demonstr
abil
kshv
induc
express
earli
stage
present
studi
analyz
effect
anoth
close
relat
ebv
express
transcript
fig
protein
express
fig
level
significantli
elev
ebv
kshv
infect
bjab
cell
express
increas
viru
infect
cell
earli
min
post
infect
pi
elev
min
min
pi
bjab
significantli
declin
min
pi
fig
observ
similar
express
profil
earli
stage
viral
infect
human
microvascular
dermal
endotheli
cell
hmvecd
cell
supplement
fig
also
perform
bind
assay
deciph
bind
kshv
ebv
enough
induc
express
bjab
cell
result
fig
demonstr
bind
wildtyp
uvinactiv
viru
enough
induc
express
result
implic
abil
induc
express
earli
stage
infect
recent
conclud
studi
demonstr
crucial
role
express
kshv
infect
cell
possibl
monitor
express
transcript
measur
infect
current
studi
analyz
intern
monitor
intern
viral
dna
fig
compar
express
transcript
fig
bjab
cell
express
support
significantli
enhanc
kshv
ebv
infect
compar
cell
left
untransfect
mock
transfect
transfect
empti
vector
authent
role
enhanc
infect
test
effect
silenc
intern
virus
briefli
first
transfect
cell
sirna
specif
northern
blot
western
blot
perform
hour
transfect
per
standard
protocol
monitor
mrna
protein
express
level
respect
maximum
mrna
fig
protein
fig
inhibit
observ
cell
transfect
sirna
specif
h
post
transfect
line
intern
cell
silenc
express
significantli
lower
compar
cell
untransfect
transfect
ns
sirna
fig
taken
togeth
result
clearli
implic
role
enhanc
kshv
ebv
infect
cell
enumer
role
bind
virus
target
cell
use
untransfect
bjab
cell
transfect
sirna
ns
sirna
cell
use
bind
assay
bind
assay
perform
bjab
cell
demonstr
transfect
cell
ns
sirna
sirna
specif
block
multipl
infect
moi
kshv
ebv
bind
target
cell
fig
incub
kshv
heparin
csa
significantli
block
kshv
ebv
bind
cell
fig
observ
ident
result
moi
supplement
fig
moi
data
shown
kshv
ebv
use
bind
assay
data
confirm
electron
microscopi
monitor
kshv
fig
c
ebv
fig
bind
bjab
cell
base
result
conclud
alter
viru
infect
postattach
stage
entri
regard
substitut
human
wide
use
vivo
use
mous
sirna
specif
appreci
effect
infect
vivo
use
balbc
mice
experiment
design
detail
schemat
fig
prime
mice
sirna
specif
significantli
lower
express
lung
mice
compar
ns
sirna
fig
data
demonstr
signific
increas
leukocyt
count
mice
infect
compar
uninfect
mice
tabl
leukocyt
count
infect
mice
prime
sirna
specif
significantli
lower
compar
prime
pb
ns
sirna
notic
atyp
lymphoid
monocyt
anim
infect
mice
monitor
tradit
plaqu
assay
plaqu
assay
could
detect
lung
infect
mice
fig
infect
significantli
inhibit
mice
prime
sirna
specif
compar
prime
ns
sirna
pb
fig
result
confirm
perform
qrtpcr
fig
taken
togeth
silenc
express
significantli
hamper
infect
mice
mani
differ
type
cellular
sensor
detect
virus
induc
express
type
interferon
ifn
type
ifn
bind
ubiquit
express
ifnar
receptor
activ
jakstat
type
ifn
respons
induc
express
hundr
interferon
stimul
gene
isg
primarili
serv
limit
viru
spread
ifitm
famili
protein
gain
popular
novel
antivir
ifitm
member
interferoninduc
aa
protein
famili
includ
famili
protein
locat
chromosom
human
genom
origin
describ
highli
induc
gene
ifn
ifitm
protein
significantli
upregul
type
ii
ifn
critic
antivir
innat
immun
recent
report
indic
ifitm
play
signific
role
viru
entri
ifitm
inhibit
entri
mani
rna
virus
includ
influenza
viru
west
nile
viru
dengu
viru
hiv
howev
ifitm
also
enhanc
viral
infect
cell
modestli
enhanc
human
papillomaviru
infect
varieti
cell
ii
zhao
et
al
shown
type
type
ii
significantli
promot
infect
human
coronaviru
induct
ifitm
protein
author
report
overexpress
significantli
increas
suscept
cell
infect
iii
inhibit
express
specif
mimic
significantli
inhibit
earli
stage
kshv
infect
human
b
endotheli
gener
ifitm
famili
protein
affect
viru
entri
cell
current
studi
demonstr
ebv
anoth
induc
express
earli
stage
infect
follow
ident
pattern
kshv
fig
b
bind
kshv
ebv
target
cell
suffici
induc
express
fig
went
one
step
demonstr
overexpress
significantli
alter
intern
fig
also
abil
establish
infect
monitor
express
respect
viral
transcript
fig
also
silenc
express
specif
sirna
result
signific
drop
number
intern
viral
particl
fig
promot
infect
postbind
stage
entri
silenc
alter
kshv
ebv
bind
cell
surfac
fig
kshv
util
hs
bind
ebv
also
interact
hs
express
epitheli
cell
via
glycoprotein
gener
speak
bjab
cell
thought
resist
kshv
ebv
primarili
b
cell
express
recent
studi
determin
bjab
cell
express
kshv
ebv
effici
infect
hand
treat
ebv
solubl
heparin
block
bind
bjab
cell
due
one
follow
reason
like
kshv
hs
may
role
play
ebv
infect
bjab
cell
ii
high
concentr
solubl
heparin
use
could
steric
bulk
effect
viru
bind
cell
awar
discrep
associ
role
hs
ebv
bind
entri
current
studi
solubl
heparin
use
control
elabor
studi
conduct
prior
rule
role
hs
ebv
entri
bjab
cell
natur
model
system
investig
interact
infect
mice
natur
pathogen
wild
therefor
understand
vivo
effect
use
model
viru
leukocyt
count
increas
respons
infect
mice
tabl
increas
leukocyt
count
significantli
lower
mice
prime
sirna
compar
ns
sirna
pb
observ
atyp
lymphoid
monocyt
mice
group
use
earli
observ
chang
prime
mice
sirna
specif
significantli
lower
express
lung
compar
pb
ns
sirna
fig
determin
plaqu
assay
qpcr
decreas
express
result
signific
decreas
infect
lung
obtain
mice
fig
c
studi
focus
primarili
monitor
infect
lung
intranas
infect
mice
result
acut
lytic
infect
lung
follow
establish
lifelong
taken
togeth
demonstr
first
time
crucial
role
vivo
infect
result
studi
put
forth
crucial
question
term
better
understand
role
alter
entri
numer
mechan
ifitm
protein
alter
viru
entri
propos
limit
follow
act
pattern
recognit
receptor
sens
viru
infect
activ
downstream
cellular
signal
pathway
ii
reduc
membran
fluiditi
curvatur
possibl
disrupt
intracellular
cholesterol
albeit
none
mechan
confirm
futur
studi
aim
delin
elud
mechan
enhanc
intern
studi
crucial
help
us
understand
role
isg
modul
infect
cell
addit
result
studi
benefit
design
target
therapi
treat
infect
includ
human
burkitt
lymphoma
b
cell
line
bjab
use
studi
bjab
cell
propag
phenol
rpmi
medium
invitrogen
carlsbad
ca
contain
charcoalstrip
fetal
bovin
serum
fb
atlanta
biolog
lawrencevil
ga
lglutamin
cell
use
studi
neg
mycoplasma
test
mycoplasma
pcr
elisa
roch
life
scienc
indianapoli
virus
use
studi
wildtyp
femal
inbr
balbc
mice
suppli
faculti
veterinari
medicin
brno
czech
republ
use
studi
gener
ultraviolet
uv
inactiv
kshv
uvkshv
ebv
uvebv
per
earli
bjab
cell
infect
multipl
infect
moi
kshv
ebv
cell
left
uninfect
infect
min
prior
wash
cell
twice
pb
process
appropri
rna
dna
extract
total
rna
extract
use
trizol
invitrogen
carlsbad
ca
rna
concentr
measur
nanodrop
spectrophotomet
thermo
fisher
scientif
waltham
verifi
qualiti
use
agil
bioanalyz
agil
technolog
santa
clara
ca
rna
sampl
ratio
use
studi
viral
dna
extract
isol
total
genom
dna
determin
intern
viru
particl
extract
rna
use
synthes
cdna
express
monitor
qrtpcr
use
specif
primer
per
earlier
express
use
scale
measur
kshv
infect
cell
report
lowest
limit
detect
standard
sampl
copi
gene
result
use
primer
consist
confirm
monitor
express
anoth
viral
immedi
earli
ie
gene
vgpcr
data
shown
ebv
infect
monitor
use
specif
primer
homolog
kshv
target
cell
transient
transfect
plasmid
dna
use
fugen
hd
promega
madison
wi
per
manufactur
recommend
plasmid
pqcxip
encod
use
studi
kindli
gift
us
dr
michael
farzan
scripp
research
institut
jupit
usa
fugen
hddna
ratio
adher
cell
line
suspens
cell
line
use
transient
transfect
experi
use
cell
conduct
h
post
transfect
express
inhibit
transfect
doublestrand
ds
rna
oligo
per
standard
sirna
purchas
dharmacon
rna
technolog
lafayett
co
briefli
untransfect
cell
cell
transfect
sirna
ns
sirna
h
infect
moi
kshv
end
min
pi
kshv
infect
assess
monitor
express
qrtpcr
effect
kshv
bind
target
cell
assess
pcr
detect
cellbound
kshv
dna
briefli
untransfect
cell
cell
transfect
ns
sirna
sirna
specif
infect
kshv
min
incub
viru
cell
wash
three
time
pb
remov
unbound
viru
cell
pellet
total
dna
includ
repres
cell
bound
kshv
isol
use
dneasi
kit
qiagen
valencia
ca
subject
qpcr
analysi
monitor
accord
recent
publish
incub
kshv
heparin
chondroitin
sulfat
csa
sigmaaldridg
h
use
known
posit
neg
control
em
studi
conduct
appreci
effect
viru
bind
cell
briefli
virus
allow
bind
bjab
cell
untransfect
transient
transfect
sirna
ns
sirna
min
cell
fix
glutaraldehyd
thin
section
examin
transmiss
electron
microscopi
number
viru
particl
adsorb
cell
membran
count
per
procedur
outlin
earlier
anim
studi
use
balbc
mice
perform
understand
effect
vivo
briefli
five
group
mice
n
use
studi
viru
free
uninfect
ii
infect
iii
sirna
prime
infect
iv
ns
sirna
prime
infect
v
pb
prime
infect
mice
prime
pb
ns
sirna
day
tail
vein
inject
uninfect
infect
group
left
untreat
day
group
iii
iv
v
tail
veininject
sirna
ns
sirna
pb
respect
step
anim
group
ii
iii
iv
v
intranas
infect
pfu
day
anim
group
iii
iv
v
receiv
tail
vein
inject
sirna
ns
sirna
pb
respect
anim
group
ii
left
undisturb
day
mice
sacrif
lung
collect
rel
gene
express
calcul
use
documentclass
minim
usepackag
amsmath
usepackag
wasysym
usepackag
amsfont
usepackag
amssymb
usepackag
amsbsi
usepackag
mathrsf
usepackag
upgreek
setlength
oddsidemargin
begin
document
triangl
triangl
c
end
document
use
mrna
express
refer
gene
viru
free
group
calibr
plaqu
conduct
determin
infect
lung
anim
experi
perform
accord
european
union
standard
fundament
ethic
principl
includ
anim
welfar
requir
respect
experi
done
approv
state
veterinari
food
administr
slovak
republ
anim
experi
perform
accord
european
union
standard
fundament
ethic
principl
includ
anim
welfar
requir
respect
experi
done
approv
state
veterinari
food
administr
slovak
republ
